AC
MRK icon

AlphaCore Capital’s Merck MRK Stock Holding History

AlphaCore Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.92M Sell
48,866
-6,488
-12% -$749K 0.14% 132
2025
Q4 		$5.87M Buy
55,354
+17,728
+47% +$1.66M 0.13% 144
2025
Q3 		$3.19M Buy
37,626
+2,423
+7% +$200K 0.11% 149
2025
Q2 		$2.81M Buy
35,203
+8,062
+30% +$641K 0.11% 151
2025
Q1 		$2.46M Buy
27,141
+3,402
+14% +$318K 0.21% 100
2024
Q4 		$2.38M Sell
23,739
-5,561
-19% -$573K 0.51% 37
2024
Q3 		$3.35M Buy
29,300
+1,281
+5% +$152K 0.76% 23
2024
Q2 		$3.49M Buy
28,019
+2,128
+8% +$274K 0.84% 21
2024
Q1 		$3.44M Buy
25,891
+157
+0.6% +$19.4K 0.91% 22
2023
Q4 		$2.83M Buy
25,734
+222
+0.9% +$23K 0.41% 46
2023
Q3 		$2.64M Buy
25,512
+1,330
+5% +$143K 0.42% 50
2023
Q2 		$2.81M Buy
24,182
+9,649
+66% +$1.1M 0.45% 45
2023
Q1 		$1.55M Buy
14,533
+2,288
+19% +$247K 0.41% 38
2022
Q4 		$1.36M Buy
12,245
+2,799
+30% +$286K 0.53% 24
2022
Q3 		$813K Buy
9,446
+2,754
+41% +$246K 0.37% 30
2022
Q2 		$610K Buy
6,692
+1,616
+32% +$143K 0.28% 39
2022
Q1 		$416K Buy
+5,076
New +$400K 0.16% 49
2020
Q2 		– Sell
-1,660
Closed -$122K – 215
2020
Q1 		$122K Buy
+1,660
New +$130K 0.1% 66

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCore Capital's MRK Position: Q1 2026 in Review

AlphaCore Capital reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $749K and leaving 48,866 shares worth $5.92M. The position accounts for 0.14% of the portfolio, ranked #132.

AlphaCore Capital first reported a position in MRK in Q1 2020 and has held it in 18 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • AlphaCore Capital held 48,866 shares of Merck worth $5.92M as of Q1 2026.
  • AlphaCore Capital sold 6,488 Merck shares in Q1 2026, an estimated $749K.
  • Merck made up 0.14% of AlphaCore Capital's portfolio in Q1 2026, its #132 holding.
  • AlphaCore Capital first reported a position in Merck in Q1 2020 and has held it in 18 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.